DE69731985T2 - Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren - Google Patents
Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren Download PDFInfo
- Publication number
- DE69731985T2 DE69731985T2 DE69731985T DE69731985T DE69731985T2 DE 69731985 T2 DE69731985 T2 DE 69731985T2 DE 69731985 T DE69731985 T DE 69731985T DE 69731985 T DE69731985 T DE 69731985T DE 69731985 T2 DE69731985 T2 DE 69731985T2
- Authority
- DE
- Germany
- Prior art keywords
- fibrinogen
- product according
- spacer
- microcapsules
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9621886.2A GB9621886D0 (en) | 1996-10-21 | 1996-10-21 | Microparticles and their therapeutic use |
| GB9621886 | 1996-10-21 | ||
| GB9702652 | 1997-02-10 | ||
| GBGB9702652.0A GB9702652D0 (en) | 1997-02-10 | 1997-02-10 | Conjugates and their preparation |
| PCT/GB1997/002877 WO1998017319A2 (en) | 1996-10-21 | 1997-10-17 | Platelet substitutes and conjugation methods suitable for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69731985D1 DE69731985D1 (de) | 2005-01-20 |
| DE69731985T2 true DE69731985T2 (de) | 2005-12-29 |
Family
ID=26310263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69731985T Expired - Lifetime DE69731985T2 (de) | 1996-10-21 | 1997-10-17 | Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5977313A (enExample) |
| EP (1) | EP1028752B1 (enExample) |
| JP (1) | JP2001504813A (enExample) |
| AR (1) | AR008680A1 (enExample) |
| AT (1) | ATE284714T1 (enExample) |
| AU (1) | AU718956B2 (enExample) |
| CA (1) | CA2269335C (enExample) |
| DE (1) | DE69731985T2 (enExample) |
| ES (1) | ES2232862T3 (enExample) |
| WO (1) | WO1998017319A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391343B1 (en) | 1991-01-15 | 2002-05-21 | Hemosphere, Inc. | Fibrinogen-coated particles for therapeutic use |
| US6264988B1 (en) | 1997-06-05 | 2001-07-24 | Hemosphere, Inc. | Fibrinogen-coated microspheres |
| GB9724143D0 (en) * | 1997-11-14 | 1998-01-14 | Andaris Ltd | Pharmaceutical conjugate |
| US20030021777A1 (en) * | 1998-02-20 | 2003-01-30 | Roy Harris | Product comprising bound fibrinogen and thrombin for use in wound therapy or surgical repair |
| GB9825105D0 (en) * | 1998-11-16 | 1999-01-13 | Andaris Ltd | Pharamaceutical conjugates |
| GB9827813D0 (en) * | 1998-12-17 | 1999-02-10 | Andaris Ltd | Pharmaceutical conjugates |
| DE19926475A1 (de) * | 1999-06-10 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Träger-Pharmaka-Konjugate |
| US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
| DE10135356C1 (de) * | 2001-07-20 | 2003-04-17 | Schering Ag | Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen |
| US7906102B2 (en) | 2001-10-03 | 2011-03-15 | Vanderbilt University | Ligands to radiation-induced molecules |
| AU2002330139A1 (en) * | 2001-10-03 | 2003-04-14 | Vanderbilt University | In vivo panning for ligands to radiation-induced molecules |
| US7306925B2 (en) | 2001-11-09 | 2007-12-11 | Vanderbilt University | Phage antibodies to radiation-inducible neoantigens |
| GB0323378D0 (en) * | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
| GB0516091D0 (en) * | 2005-08-04 | 2005-09-14 | Haemostatix Ltd | Therapeutic agent |
| US20080015145A1 (en) * | 2006-07-11 | 2008-01-17 | Maria Gyongyossy-Issa | Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| US20110077202A1 (en) * | 2008-05-16 | 2011-03-31 | Bayer Healthcare Llc | Targeted Coagulation Factors and Method of Using the Same |
| US9119897B2 (en) | 2009-05-28 | 2015-09-01 | Profibrix B.V. | Dry powder fibrin sealant |
| GB201101740D0 (en) * | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
| WO2013019730A1 (en) | 2011-07-29 | 2013-02-07 | The Washington University | Antibodies to tip-1 and grp78 |
| GB201201751D0 (en) | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| US20130202675A1 (en) | 2012-02-03 | 2013-08-08 | Dynasil Biomedical Corporation | Systems and methods for the fabrication of tissue patches |
| GB201204868D0 (en) | 2012-03-20 | 2012-05-02 | San Raffaele Centro Fond | Peptides |
| WO2016014939A1 (en) | 2014-07-24 | 2016-01-28 | Washington University | Compositions targeting radiation-induced molecules and methods of use thereof |
| US9833538B2 (en) | 2015-08-07 | 2017-12-05 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| WO2017027378A1 (en) | 2015-08-07 | 2017-02-16 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| US9540548B1 (en) | 2015-08-07 | 2017-01-10 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| CN107686507B (zh) * | 2016-08-05 | 2021-02-12 | 首都医科大学 | Rgds-阿霉素,其合成,活性和应用 |
| CN107686508B (zh) * | 2016-08-05 | 2021-02-12 | 首都医科大学 | 阿霉素-rgds,其合成,活性和应用 |
| WO2018148595A1 (en) | 2017-02-10 | 2018-08-16 | Washington University | Antibodies to tip1 and methods of use thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
| GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
| US4661471A (en) * | 1984-04-10 | 1987-04-28 | New England Deaconess Hospital | Method of inhibiting and inducing human platelet aggregation |
| US4666884A (en) * | 1984-04-10 | 1987-05-19 | New England Deaconess Hospital | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls |
| US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
| AU3149289A (en) * | 1988-03-18 | 1989-09-21 | Rockefeller University, The | Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor |
| DE68924783T2 (de) * | 1988-09-30 | 1996-03-28 | Neorx Corp | Wässrige additivsysteme, verfahren und polymerteilchen. |
| DE69118861T2 (de) * | 1991-01-10 | 1996-09-05 | Basf Corp | Verfahren zur Vernetzen von Gelatine und Aufnahme eines Materials |
| US5616311A (en) * | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| US5725804A (en) * | 1991-01-15 | 1998-03-10 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| ATE147976T1 (de) * | 1991-01-15 | 1997-02-15 | Hemosphere Inc | Protein nanomatrizen und verfahren zur herstellung |
| AU1461592A (en) * | 1991-02-07 | 1992-09-07 | Fibratek, Inc. | Fibrinogen based adhesive |
| WO1992013547A1 (en) * | 1991-02-07 | 1992-08-20 | Alexander Mellon Eaton | Drug delivery composition and method of using the same |
| GB9107628D0 (en) * | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
| WO1994013692A1 (en) * | 1992-12-10 | 1994-06-23 | Regents Of The University Of Minnesota | Polypeptides useful for treating inflammatory disorders |
| GB9423419D0 (en) * | 1994-11-19 | 1995-01-11 | Andaris Ltd | Preparation of hollow microcapsules |
| DE69529917T2 (de) * | 1994-12-16 | 2003-12-11 | Elan Drug Delivery Ltd., Ruddington | Vernetzte mikropartikel und ihre verwendung als arzneiträger |
| EP0727225A3 (en) * | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions and methods for directed ultrasonic imaging |
| EP0831793A4 (en) * | 1995-06-06 | 2000-11-15 | Hemosphere Inc | PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE |
-
1997
- 1997-10-17 AU AU47135/97A patent/AU718956B2/en not_active Ceased
- 1997-10-17 EP EP97909451A patent/EP1028752B1/en not_active Expired - Lifetime
- 1997-10-17 DE DE69731985T patent/DE69731985T2/de not_active Expired - Lifetime
- 1997-10-17 AT AT97909451T patent/ATE284714T1/de active
- 1997-10-17 JP JP51910098A patent/JP2001504813A/ja active Pending
- 1997-10-17 US US08/953,514 patent/US5977313A/en not_active Expired - Lifetime
- 1997-10-17 ES ES97909451T patent/ES2232862T3/es not_active Expired - Lifetime
- 1997-10-17 WO PCT/GB1997/002877 patent/WO1998017319A2/en not_active Ceased
- 1997-10-17 CA CA2269335A patent/CA2269335C/en not_active Expired - Fee Related
- 1997-10-20 AR ARP970104847A patent/AR008680A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1028752B1 (en) | 2004-12-15 |
| ES2232862T3 (es) | 2005-06-01 |
| WO1998017319A3 (en) | 1998-06-11 |
| JP2001504813A (ja) | 2001-04-10 |
| DE69731985D1 (de) | 2005-01-20 |
| AU718956B2 (en) | 2000-05-04 |
| AR008680A1 (es) | 2000-02-09 |
| ATE284714T1 (de) | 2005-01-15 |
| WO1998017319A2 (en) | 1998-04-30 |
| CA2269335A1 (en) | 1998-04-30 |
| CA2269335C (en) | 2010-05-25 |
| EP1028752A2 (en) | 2000-08-23 |
| US5977313A (en) | 1999-11-02 |
| AU4713597A (en) | 1998-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5977313A (en) | Platelet substitutes and conjugation methods suitable for their preparation | |
| DE69529917T2 (de) | Vernetzte mikropartikel und ihre verwendung als arzneiträger | |
| DE3382572T2 (de) | Antikoerper-verbindungen. | |
| US5258499A (en) | Liposome targeting using receptor specific ligands | |
| US5972707A (en) | Gene delivery system | |
| DE69434725T2 (de) | Zell- und Serumproteinanker und Konjugate | |
| DE69310527T2 (de) | Mittel zur Behandlung entzündeter Gewebe | |
| Torchilin et al. | Poly (ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium | |
| DE69532970T2 (de) | Sprühgetrocknetes erythropoietin | |
| EP1392255B1 (de) | Nanopartikel aus protein mit gekoppeltem apolipoprotein e zur überwindung der blut-hirn-schranke und verfahren zu ihrer herstellung | |
| DE69116144T2 (de) | Bindung substratspezifischer affinitätssubstanzen an liposomen | |
| EP0571414B1 (de) | Neue, über endozytose in höhere eukaryotische zellen aufnehmbare, nukleinsäure enthaltende komplexe | |
| US5955108A (en) | Cross-linked microparticles and their use as therapeutic vehicles | |
| US5366958A (en) | Localized delivery using fibronectin conjugates | |
| DD209578A5 (de) | Verfahren zur herstellung von immunoenzymatischen konjugaten | |
| EP0366770B1 (en) | Liposomes coupled to hormones | |
| DE69829880T2 (de) | Konjugate enthaltend zwei wirkstoffe | |
| JP2001523648A5 (enExample) | ||
| DE3738721C2 (de) | Immobilisierte Antikörper | |
| JPH07507272A (ja) | 部位特異性デリバリー機能を有する医薬組成物 | |
| EP1466614A1 (de) | Polypeptid, dessen konjugat doxorubicin enthält, und auf diesem basierende pharmazeutische zusammensetzung | |
| JPH05238951A (ja) | モルホリノアントラサイクリンの抗体への化学結合 | |
| DE69229356T2 (de) | NEUE VERBESSERUNGEN hinsichtlich der RADIOMARKIERUNG von PROTEINEn | |
| US6706713B1 (en) | Conjugate for treating inflammatory infectious and/or skin diseases | |
| EP0577146A2 (en) | Liposomes coupled to hormones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8363 | Opposition against the patent |